Search clinical trials for: Phase I, healthy, pharmacokinetics, food effect.

Total 51975 results

University Hospital, Angers

Unknown

High Dose Hyperoncotic Serum Albumin for the Treatment of the Acute Phase of Severe Head Injury

Severe Head Injury

France
Poitiers University Hospital
Novartis; Ministry of Health, France

Terminated

Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients

Chronic Myeloid Leukemia

France
National Taiwan University Hospital
National Health Research Institutes, Taiwan

Completed

A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma
Far Eastern Memorial Hospital

Completed

Dexamethasone-Eluting Stent in Acute Coronary Syndrome to Prevent Restenosis

Vessel Restenosis
Children's Memorial Health Institute, Poland

Completed

Comparison of Immunosuppression Protocols After LTx in Children

Liver Transplantation

Poland
University Hospital, Gentofte, Copenhagen

Unknown

Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.

Type 2 Diabetes

Denmark
University of Calgary
Stewart Diabetes Education Fund

Completed

Use of a Portion Control Food Tool to Induce Weight Loss in Obese Type 2 Diabetics.

Obesity | Type 2 Diabetes Mellitus

Canada
Boston University

Completed

Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia

Beta-Thalassemia

United States, United Kingdom
Celgene Corporation
Prologue Research International

Terminated

Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Celgene Corporation
Prologue Research International

Terminated

A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas

Pancreatic Cancer

United States
Zeneus Pharma

Unknown

Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.

Aggressive Non-Hodgkin's Lymphoma in the Elderly.

France, Germany, Spain, United Kingdom, Italy
University Hospital, Rouen

Completed

Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial

Esophageal Neoplasms

France
Cell Genesys

Completed

A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer | Nonresectable Pancreatic Cancer

United States
University Hospital, Angers
French Innovative Leukemia Organisation

Unknown

Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia

Adult Acute Lymphoblastic Leukemia

France
Agency for Healthcare Research and Quality (AHRQ)

Completed

Optimizing Antibiotic Use in Long Term Care

Urinary Tract Infection, Antibiotic Use

Canada
Integrated Community Oncology Network
Sanofi

Unknown

Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.

Previously Treated Metastatic Non-Small Cell Lung Cancer

United States
Makerere University
NUFU

Unknown

Ready to Use Therapeutic Food in the Rehabilitation of Severely Malnourished Children

Malnutrition

Norway, Uganda
Wageningen Centre for Food Sciences
Wageningen University

Completed

Bioavailability of Folate From a Mixed Diet Using a Stable Isotope Method

Healthy | Folate Bioavailability

Netherlands
Kyoto University, Graduate School of Medicine

Unknown

Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure

Liver Failure, Acute

Japan
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Completed

Early Labour Assessment and Support at Home

Latent Phase Labour
University of Toronto

Completed

Canadian Trial of Dietary Carbohydrates in Diabetes

Type 2 Diabetes

Canada
Department of Veterans Affairs, New Jersey
Sanofi; Pfizer

Unknown

A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer

Prostate Cancer

United States
The Miriam Hospital

Completed

Liking of Snack Foods - Sub-Study 1

Obesity | Eating Behavior | Satiation

United States
Johns Hopkins Bloomberg School of Public Health
American Diabetes Association

Completed

Long Term Free Living Study With Modified Foods and Type 2 Diabetics

Obesity | Type 2 Diabetes Mellitus

United States
Johns Hopkins Bloomberg School of Public Health
Procter and Gamble

Completed

Olestra Containing Foods and Weight Loss and Weight Maintenance

Obesity

United States
Association Européenne de Recherche en Oncologie
Amgen; Aventis Pharmaceuticals

Completed

Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast Cancer

Node Positive Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE.

LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE UCNT

France
Stanford University
Robert Wood Johnson Foundation

Completed

Effects of Advertising on Young Children's Perception of Taste

Obesity

United States
University of British Columbia
National Cancer Institute (NCI)

Completed

A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide)

Lung Cancer

Canada
National Taiwan University Hospital

Unknown

The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients

Kidney Transplantation | Immunosuppression | Transplantation

Taiwan
National Taiwan University Hospital

Unknown

Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets

Kidney Transplantation | Immunosuppression | Transplantation

Taiwan
National Taiwan University Hospital
National Health Research Institutes, Taiwan

Completed

Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

Taiwan
Khon Kaen University

Completed

Pre-Emptive Analgesia Efficacy of Etoricoxib for Postoperative Pain

a Single-Dose of Etoricoxib | Post-Operative Morphine Consumption | Total Pain Relief Over 8 Hr(TOPAR8) | Post Transabdominal Hysterectomy

Thailand
UMC Utrecht
Dutch Kidney Foundation; Dianet Dialysis Centers

Completed

Effects of Daily Home Hemodialysis on Circulation, Mental Functions, and Quality of Life

End-Stage Renal Disease

Netherlands
Royal Brompton & Harefield NHS Foundation Trust

Unknown

Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation

Lung Diseases | Bronchiectasis | Emphysema | Cystic Fibrosis | Alveolitis, Fibrosing

United Kingdom
West Japan Thoracic Oncology Group

Completed

A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer

Lung Cancer
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
Pharmasset

Completed

A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males

HIV Infections
Pharmasset

Completed

A Study of DPC 817 in HIV-Infected Males

HIV Infections

United States, Germany
Sandoz

Completed

A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

HIV Infections | Cytopenias

United States
G D Searle

Completed

Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3

HIV Infections

United States
National Center for Research Resources (NCRR)
Oregon Health and Science University

Unknown

Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis

Cerebrotendinous Xanthomatosis

United States
National Center for Research Resources (NCRR)
James Whitcomb Riley Hospital for Children

Completed

Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes

Thrombocytopenia | Dyskeratosis Congenita | Fanconi's Anemia | Shwachman Syndrome
G D Searle

Completed

Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)

HIV Infections

United States
National Center for Research Resources (NCRR)
University of Pennsylvania

Completed

Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia

Familial Hypercholesterolemia
Genentech, Inc.

Completed

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex

HIV Infections

United States
Nexstar Pharmaceuticals

Completed

A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.

HIV Infections | Sarcoma, Kaposi

United States
National Center for Research Resources (NCRR)
University of Pittsburgh

Unknown

Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease

Gaucher's Disease

United States
National Center for Research Resources (NCRR)
Mayo Clinic

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Search clinical trials for: Phase I, healthy, pharmacokinetics, food effect.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations